News Headlines Article

Paying for treatment of rare diseases
Sacramento Bee

In the past, people with rare diseases often had far fewer treatment options. The reason was pure economics – supply and demand.

If you were a drug company, would you rather invest in research and development to produce a drug that tens of millions of people could take or one that would benefit only 5,000 to 10,000 people with a rare disease?